Bellinzona, Switzerland – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will allow the company to expand its team and to commercialize its governed self-service analytics (GSSA) platforms to empower life scientists. BigOmics raised $1.42 million on the first closing of […]
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving […]
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving […]
Genedata Screener to be adopted worldwide at AstraZeneca for all in-vitro testing, focusing on biotherapeutics discovery as well as specialized modalities of PROTACs and CRISPR. Basel, Switzerland — Genedata, a leading provider of enterprise software solutions for biopharma R&D, today announced an expanded licensing agreement with AstraZeneca for Genedata Screener® which will support the company’s […]
HELSINKI, Finland — Euformatics, Finnish bioinformatics software company, has today announced that its genomic variant interpretation and reporting tool, omnomicsNGS, has been granted the CE-IVD mark under the In-Vitro Diagnostics Directive (98/79/EC). The software, previously a CE-marked medical device class I under preceding EU legislation, is now making strong progress on its journey to being […]
Next Generation Sequencing Software to Help Antibody Engineers, Bioinformaticians Uncover Potential Antibody Therapeutics SANTA FE, N.M. – OpenEye Scientific and Specifica, Inc., today announced they are releasing jointly developed software to help antibody engineers and bioinformaticians at pharmaceutical and biotechnology companies advance antibody discovery by identifying diverse antibody sets with better properties for downstream therapeutics […]
Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enroll 4,000 patients from approximately 30 sites across North America, Europe, and Latin America BOSTON and […]
Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that MiNK Therapeutics has partnered with Genedata to deploy its workflow platform, Genedata Biologics®, for support of their iNKT cell therapy pipeline programs. “Given their track-record of success, Genedata’s platform was the clear choice to support and integrate our full […]
Free Google Chrome Extension to 14 Variant Databases Accelerates Genomic Interpretation and Research Genomenon, Inc.®, an AI-driven genomics company, today announced the new Mastermind Search Companion, a Google Chrome browser plug-in for use with 14 variant databases, Google, and Google Scholar. The free extension, available through the Chrome Web Store to all Google Chrome users enables deeper […]
New capabilities increase efficiency in analyzing and developing small molecules and biologic drugs Princeton, N.J. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of D360 version 21.5, an industry-leading scientific informatics software for discovery scientists to integrate many data sources and analyze small molecules and biologic drugs for fast, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
